NCT04819581View on ClinicalTrials.gov

Pharmacokinetic Study of SP-103 in Healthy Adult Human Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 3, 2019

Primary Completion Date

August 27, 2019

Study Completion Date

August 27, 2019

Conditions
Healthy
Interventions
DRUG

SP-103

lidocaine topical system 5.4%

DRUG

ZTlido

lidocaine topical system 1.8%

Trial Locations (1)

56529

AXIS Clinicals, Dilworth

All Listed Sponsors
lead

Scilex Pharmaceuticals, Inc.

INDUSTRY

NCT04819581 - Pharmacokinetic Study of SP-103 in Healthy Adult Human Subjects | Biotech Hunter | Biotech Hunter